CAM
BMY.RT

Chesapeake Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Chesapeake Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$71K Buy
+23,499
New +$61.1K 0.12% 44

Other funds holding BMY.RT

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Chesapeake Asset Management's BMY.RT Position: Q4 2019 in Review

Chesapeake Asset Management opened a new position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q4 2019: 23,499 shares worth $71K. The stake represents 0.12% of the portfolio and ranks #44 among its holdings.

616 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2019.

  • Chesapeake Asset Management held 23,499 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $71K as of Q4 2019.
  • Bristol-Myers Squibb Company Contingent Value Rights was a new Chesapeake Asset Management position in Q4 2019.
  • Bristol-Myers Squibb Company Contingent Value Rights made up 0.12% of Chesapeake Asset Management's portfolio in Q4 2019, its #44 holding.
  • 616 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2019.

Based on Chesapeake Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.